Cerus Corporation to raise approximately $12.2 million by selling stocks and warrants

NewsGuard 100/100 Score

Cerus Corporation (NASDAQ:CERS) today announced that it has entered into definitive agreements with selected investors to sell 6,000,000 units, with each unit consisting of (i) one share of the Company’s common stock and (ii) a warrant to purchase 0.4 of a share of the Company’s common stock for gross proceeds of approximately $13.2 million in a “registered direct” offering.

The Company estimates that net proceeds from the offering will be approximately $12.2 million, after deducting placement agent fees and estimated offering expenses. The investors have agreed to purchase the units at a purchase price of $2.20 per unit. The warrants, which represent the right to acquire an aggregate of up to 2,400,000 shares of the Company’s common stock, will have a five-year term from the date of issuance, will be exercisable beginning six months after the date of issuance and will be exercisable at a price of $2.90 per share. The transaction is expected to close on or about August 25, 2009, subject to the satisfaction of customary closing conditions. The net proceeds from the transaction are expected to be used for working capital and general corporate purposes.

Cowen and Company, LLC, a subsidiary of Cowen Group, Inc. (NASDAQ:COWN), acted as the exclusive placement agent for the transaction.

The securities described above are being offered by Cerus Corporation pursuant to effective registration statements previously filed with the Securities and Exchange Commission.

Posted in:

Tags:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.